SOLIUS White Paper Released: Explores Potential Impact of Vitamin D On COVID-19

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

May 20, 2020

SOLIUS white paper on the potential impact vitamin D may have on treating and preventing COVID-19 has been released  Request white paper here.

SOLIUS notes Vitamin D is not just a nutrient; it’s a hormone with receptors in nearly every cell and tissue of the body. Vitamin D functions as both a genetic and immune modulator and its widespread impact on different systems in the body are well known, offering a multi-pronged approach for maintaining a healthy immune system. Taking oral vitamin D supplements does not show similar results with any consistency. This is likely due to the very different way the body uses sunlight to produce hormones.

Early research suggests a potential link between vitamin D and COVID-19 outcomes. Several correlational studies have found an association between low levels of vitamin D and susceptibility to acute respiratory tract infections. Researchers from Northwestern University found a correlation between vitamin D levels and cytokine storms, a condition caused by an overactive immune system often seen in the most severe COVID-19 patients. Another study from Anglia Ruskin University in the United Kingdom found an association between low average levels of vitamin D and high numbers of COVID-19 cases and mortality rates across 20 European countries.

While more clinical trials are needed to determine if endogenously created vitamin D could be effective for the prevention and treatment of COVID-19, studies show that vitamin D plays a role in supporting innate and adaptive immune response, decreasing the risk and severity of respiratory infections, and maintaining balance in the Renin-Angiotensin system which helps control inflammatory response in the body.

The SOLIUS technology stimulates the production of vitamin D in the skin using a narrow spectrum of ultraviolet B (UVB) light. This technology can produce 10x more vitamin D than the sun, using 100x less ultraviolet energy. According to Bob Wise, CEO, “We are currently pursuing an ambitious research strategy, working with leading phototherapy and vitamin D experts, to study the impact vitamin D and SOLIUS may have on treating and preventing COVID-19.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.